PATENT CLAIM ANALYSIS

Application Number: 16103096
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "248000"]

Abstract:
The specification describes the use of selected DPP IV inhibitors for the treatment of physiological functional disorders and for reducing the risk of the occurrence of such functional disorders in at-risk patient groups. In addition, the use of the above-mentioned DPP IV inhibitors in conjunction with other active substances is described, by means of which improved treatment outcomes can be achieved. These applications may be used to prepare corresponding medicaments.

Claim (Index 16):
The method of  claim 8 , wherein the macrovascular complication heart failure.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 96.0
- Lexical Diversity: 1.44231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11744703', '15372702', '12673327', '14161007', '12946193']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8119144879563625
- 35 USC 102 Novelty (BERT): 0.5383296934659144
- Combined Prediction Score: 0.7845560085073177
- Mean Citation Score: 380.644678
- Max Citation Score: 410.97845
- Similarity Product: 212.5827437123537

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test